Step therapy denials rarely show up on day one. They surface weeks later, after your practice already provided the care. By then, the claim sits unpaid and your staff chases an authorization that should have happened first.

What Step Therapy Means For Your Billing Team

Step therapy is a payer rule. It requires a patient to try a lower-cost drug before the insurer covers the one a provider prescribed.

Payers call this a fail first protocol. If the preferred drug fails or causes problems, the provider can request the next step.

For billing teams, step therapy works like a prior authorization rule tied to specific drug codes. It applies most often to injectable biologics, GLP-1 medications, and certain psychiatric drugs.

How Step Edits Trigger Claim Denials

Payer systems run step edits before paying a claim. If the patient’s history shows no documented trial of the preferred drug, the claim denies.

Common denial reasons include missing prior authorization and step requirement not met. These denials often arrive weeks after the date of service, after your team already filed the claim.

By the time the denial posts, the appeal clock is already running.

Schedule a free billing review with SwiftCare Billing before step therapy denials build up in your aging report.

Step Therapy vs Standard Prior Authorization

Step therapy is a type of prior authorization, but the two are not identical. Standard prior authorization asks the payer to approve a service before it happens.

Step therapy adds a sequence requirement on top of that. The payer will not approve the requested drug until the patient tries and fails a specific drug first.

For your billing team, this distinction matters for how you fix a denial. A standard prior authorization denial often just needs the missing authorization number. A step therapy denial needs proof of the earlier drug trial.

The Real Cost of Step Therapy Denials on Your Revenue Cycle

Step therapy denials do not stop at one claim. They create rework across your entire billing cycle.

Your staff has to pull chart notes, request medical necessity letters, and resubmit with full documentation. Each resubmission adds days to your average reimbursement time.

For drugs your practice administers and bills directly, a step therapy denial is a direct loss. You already purchased and gave the medication, so a write off means real money out the door.

A single step therapy resubmission can take a staff member 30 to 45 minutes to research and document. Multiply that across dozens of denials each month. Step therapy then becomes a steady drain on staff hours, not just unpaid claims.

Why GLP-1 and Biologic Claims Face Heavy Step Therapy Rules

GLP-1 medications carry some of the strictest step therapy rules in any drug class right now. Payers often require a documented trial of metformin or another first-line drug before approving these prescriptions.

Claims for weight loss indications face even tighter scrutiny. Many plans deny these claims outright unless the chart shows specific BMI or comorbidity criteria.

Biologics for rheumatology, dermatology, and gastroenterology follow similar patterns. Payers expect documented trials of conventional therapies before they approve the higher-cost biologic.

Many GLP-1 prescriptions also carry HCPCS codes that need their own prior authorization, separate from the step therapy check. A denial can stem from either requirement, so your team needs to confirm which one triggered the rejection before resubmitting.

Documentation Your Team Needs Before Resubmission

A clean step therapy resubmission needs specific proof. Without it, the payer denies the claim again.

Your documentation should include:

• Prior drug trial notes
• Documented side effects
• Contraindication records
• Lab results showing need
• Medical necessity letter

Gathering this after the denial wastes time your staff does not have. Practices that collect it during the visit resubmit faster and get paid sooner. Build this step into intake for any patient on a specialty medication, before the first claim goes out.

How Step Therapy Appeals and Exceptions Work

If a step therapy denial stands, your practice has appeal rights. Most payers allow an internal appeal first.

If the internal appeal fails, your provider can request a peer to peer review with the payer’s medical director. This step resolves many step therapy denials.

Many states also have step therapy exception laws. These laws let providers bypass a required step if the preferred drug is medically inappropriate for that patient.

When a Patient Is Already Stable on a Medication

Some of the hardest step therapy denials involve patients who switched insurance while stable on a medication. The new payer’s formulary may require a step the patient already completed years ago, under a different plan.

Continuity of care exceptions exist for this exact situation. Your documentation should show the patient’s full treatment history, not just the current chart.

These appeals succeed more often when records from the prior plan are attached. Ask the patient’s previous practice for records if your chart does not go back far enough.

Talk with our billing team about building a step therapy appeal workflow for your practice.

Building a Step Therapy Tracking Process for Your Practice

Step therapy denials get lost easily inside a general denial report. Without a separate category, they blend into your normal aging report and nobody owns the follow-up.

Your tracking process should separate step therapy denials by drug, by payer, and by days outstanding. This makes patterns visible fast.

A simple weekly report should show:

• New denials
• Pending documentation
• Appeals in progress
• Resolved this week

Once your team reviews these numbers weekly, step therapy stops being a surprise. It becomes one more line item your billing team manages on schedule.

Specialties Where Step Therapy Creates the Most Denials

Step therapy is not evenly spread across specialties. Some specialties see it on nearly every specialty drug claim they submit.

Practices in these fields run into step therapy most often:

• Rheumatology
• Gastroenterology
• Dermatology
• Psychiatry and mental health
• Endocrinology

Our mental health billing services work through step therapy requirements on psychiatric medications every week. Practices in these specialties need a billing partner who tracks these denials by drug, not just by claim status.

How SwiftCare Billing Handles Step Therapy Claims

Our team tracks every denial back to its root cause. Step therapy denials get flagged for documentation, not written off.

We handle:

• Denial tracking by reason
• Documentation requests
• Resubmission and appeals
• Authorization status reports

We also flag medications likely to trigger step therapy before the claim goes out, so your staff can attach documentation upfront. This keeps step therapy from becoming a permanent gap in your collections. Our prior authorization support services connect directly to this process, so denials get caught before they age past 90 days.

Get Help With Step Therapy Denials

Step therapy is not going away. Payers keep expanding it to new drug classes every year.

The practices that handle it best build a process before the denials start. Request a free billing audit and we will show you where step therapy is costing your practice money.

Frequently Asked Questions About Step Therapy and Medical Billing

What is step therapy in medical billing?

Step therapy is a payer requirement that a patient try a lower-cost medication before the insurer covers a more expensive one. For billing teams, it works as a prior authorization rule tied to specific drug codes. Billing teams often see it as a sudden denial on a claim that looked clean when submitted.

How does step therapy cause claim denials?

Payer systems check the patient’s medication history before paying a claim. If no record shows the required prior drug trial, the claim denies automatically.

Which specialties see the most step therapy denials?

Rheumatology, gastroenterology, dermatology, psychiatry, and endocrinology see the highest volume. These specialties prescribe more biologics and specialty drugs that fall under step protocols. GLP-1 prescriptions for diabetes and weight management have added significant volume to this list in recent years.

What documentation supports a step therapy exception?

Prior drug trial notes, documented side effects, contraindication records, lab results, and a medical necessity letter all support an exception request.

Can a step therapy denial be appealed?

Yes. Most payers allow an internal appeal first, followed by a peer to peer review with the payer’s medical director if needed.

How long does a step therapy exception take to process?

Timelines vary by payer and by state. Some states require expedited review when delaying treatment could put the patient at risk. Your billing team should follow up if no response arrives within the payer’s standard prior authorization window.

Does Medicare apply step therapy to Part B drugs?

Medicare Advantage plans may apply step therapy to certain Part B drugs administered in a provider’s office, under CMS guidelines. When this applies, your practice still needs documentation on file before submitting the claim for the higher-step drug.